Trial of baclofen in amyotrophic lateral sclerosis.
A trial of the antispastic drug baclofen was made in amyotrophic lateral sclerosis. Some patients noted reduction of tonus and spasticity; but others had no benefit, nor was the course of the disease altered by long-term administration of baclofen. No major side effects occurred.
D000328:Adult; D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D001418:Baclofen / Q000627:therapeutic use*; D004311:Double-Blind Method; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008875:Middle Aged
D001418:Baclofen